Four early-career researchers receive leadership grants
Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians
Four researchers at The Neuro 鈥� Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton 鈥� have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
AI-analyzed blood test can predict the progression of neurodegenerative disease
New technique could be used to choose best therapies for patients and measure their effectiveness
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient鈥檚 progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.
Unique brain 鈥渇ingerprint鈥� can predict drug effectiveness
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine 鈥� delivering therapies specially tailored to a patient鈥檚 unique physiology 鈥� has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
鈥淏ig Data鈥� study discovers earliest sign of Alzheimer鈥檚 development
Research underlines importance of computational power in future neurological breakthrough
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer鈥檚 disease (LOAD), identifying its first physiological signs.
